Z-2603-2023 Class II Ongoing

Recalled by Encore Medical, LP — Austin, TX

FDA device recall Z-2603-2023 was initiated by Encore Medical, LP on Aug 4, 2023 and is designated Class II. Reason for recall: Orthopedic device components were not subjected to final sterilization before shipment, which if implanted may lead to varying degrees of infection, which may require treatment, prolonged monitoring… The recall status is ongoing. Affected quantity: 20.

Recall details

Product Type
Devices
Report Date
Sep 27, 2023
Initiation Date
Aug 4, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20

Product description

DJO Surgical: Empowr Knee, Universal Tibia Baseplate, 6R, REF: 352-02-106

Reason for recall

Orthopedic device components were not subjected to final sterilization before shipment, which if implanted may lead to varying degrees of infection, which may require treatment, prolonged monitoring, and may lead to revision surgery

Distribution pattern

US: AL, AZ, CA, CO, FL, IL, IN, KS, KY, LA, MA, MI, MN, MO, NC, NJ, NY, OH, PA, PR, RI, SC, TX, UT, VA, WA. OUS: Sweden, Australia, France, UK, Colombia, Germany

Code information

UDI-DI/Lot/Expiration: 00190446258032/308V1112/May 25, 2029

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2603-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2603-2023. Report a data issue: hello@regdatalab.com.